High prevalence of type b β-lactamase-non-producing ampicillin-resistant Haemophilus influenzae in meningitis:: the situation in Japan where Hib vaccine has not been introduced

被引:54
作者
Hasegawa, Keiko
Kobayashi, Reiko
Takada, Emi
Ono, Akiko
Chiba, Naoko
Morozumi, Miyuki
Iwata, Satoshi
Sunakawa, Keisuke
Ubukata, Kimiko
机构
[1] Kitasato Univ, Kitasato Inst Life Sci, Lab Infect Agents Surveillance, Minato Ku, Tokyo 108, Japan
[2] Natl Hosp Org, Tokyo Med Ctr, Tokyo 108, Japan
[3] Kitasato Univ, Sch Med, Dept Infect Dis, Kanagawa, Japan
关键词
H; influenzae; BLNAR; PCR;
D O I
10.1093/jac/dkl142
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To study yearly changes in resistance and to identify ftsl mutations in beta-lactamase-non-producing ampicillin-resistant (BLNAR) and TEM-1 beta-lactamase-producing amoxicillin/clavulanic acid-resistant (BLPACR) isolates of Haemophilus influenzae from patients with meningitis. Methods: Between January 2000 and December 2004, we received 621 isolates of H. influenzae from 285 member institutions of the Nationwide Surveillance Study Group for Bacterial Meningitis. All isolates were analysed by PCR to identify resistance genes and tested for susceptibility to beta-lactams. The ftsl gene was sequenced in all BLNAR and BLPACR isolates. Results: All but four isolates were of serotype b. The isolates could be divided into six classes, namely beta-lactamase-non-producing ampicillin-susceptible (25.0%), TEM-1 P-lactamase-producing ampicillin-resistant (11.0%), beta-lactamase-non-producing low-level ampicillin-resistant with N526K or R517H substitution in the ftsl gene (30.4%), BLNAR with an S385T substitution together with either N526K or R517H substitution in ftsl (22.2%), BLPACR-1 with either a N526K or R517H substitution in ftsl (9.5%) and BLPACR-II with an S385T substitution together with either a N526K or R517H substitution in ftsl (1.9%). The prevalence of BLNAR has increased rapidly, from 5.8% in 2000 to 34.5% in 2004. All BLNAR and BLPACR-II strains were classified into nine subgroups on the basis of substitution patterns in the ftsl gene. The MICs of cephalosporin antibiotics for H. influenzae transformants into which the ftsl genes from BLNAR strains of each of the nine subgroups were introduced increased to varying degrees depending on the mutations. Conclusions: The results suggest that introduction of H. influenzae type b (Hib) vaccination into infants and children is necessary for the prevention of severe Hib infections in Japan.
引用
收藏
页码:1077 / 1082
页数:6
相关论文
共 20 条
[1]  
Arimasu O, 1988, Kansenshogaku Zasshi, V62, P682
[2]   Diversity of β-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae [J].
Dabernat, H ;
Delmas, C ;
Seguy, M ;
Pelissier, R ;
Faucon, G ;
Bennamani, S ;
Pasquier, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (07) :2208-2218
[3]  
DAVID NG, 2000, GUIDE ANTIMICROBIAL
[4]   Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: Results of a national multicenter surveillance study [J].
Doern, GV ;
Brueggemann, AB ;
Pierce, G ;
Holley, HP ;
Rauch, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (02) :292-297
[5]   Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children [J].
Goldwater, PN .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 (05) :408-411
[6]   Rapidly increasing prevalence of β-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae type b in patients with meningitis [J].
Hasegawa, K ;
Chiba, N ;
Kobayashi, R ;
Murayama, SY ;
Iwata, S ;
Sunakawa, K ;
Ubukata, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (05) :1509-1514
[7]   Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States [J].
Hasegawa, K ;
Yamamoto, K ;
Chiba, N ;
Kobayashi, R ;
Nagai, K ;
Jacobs, MR ;
Appelbaum, PC ;
Sunakawa, K ;
Ubukata, K .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 2003, 9 (01) :39-46
[8]  
Heikki P, 2000, CLIN MICROBIOL REV, V13, P302
[9]   SEQUENCE-ANALYSIS AND EVOLUTIONARY PERSPECTIVES OF ROB-1 BETA-LACTAMASE [J].
JUTEAU, JM ;
LEVESQUE, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (07) :1354-1359
[10]   CHARACTERIZATION OF NON-BETA-LACTAMASE-MEDIATED AMPICILLIN RESISTANCE IN HEMOPHILUS-INFLUENZAE [J].
MENDELMAN, PM ;
CHAFFIN, DO ;
STULL, TL ;
RUBENS, CE ;
MACK, KD ;
SMITH, AL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (02) :235-244